1
|
Lyons K, Le LC, Pham YTH, Borron C, Park
JY, Tran CTD, Tran TV, Tran HTT, Vu KT, Do CD, et al: Gastric
cancer: Epidemiology, biology, and prevention: A mini review. Eur J
Cancer Prev. 28:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25,676,887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Park YM, Cho E, Kang HY and Kim JM: The
effectiveness and safety of endoscopic submucosal dissection
compared with endoscopic mucosal resection for early gastric
cancer: A systematic review and metaanalysis. Surg Endosc.
25:2666–2677. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Choi MK, Kim GH, Park DY, Song GA, Kim DU,
Ryu DY, Lee BE, Cheong JH and Cho M: Long-term outcomes of
endoscopic submucosal dissection for early gastric cancer: A
single-center experience. Surg Endosc. 27:4250–4258. 2013.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Takahashi T, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers
(Basel). 5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Becker-Santos DD, Lonergan KM,
Gronostajski RM and Lam WL: Nuclear factor I/B: A master regulator
of cell differentiation with paradoxical roles in cancer.
EBioMedicine. 22:2–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Dooley AL, Winslow MM, Chiang DY, Banerji
S, Stransky N, Dayton TL, Snyder EL, Senna S, Whittaker CA, Bronson
RT, et al: Nuclear factor I/B is an oncogene in small cell lung
cancer. Genes Dev. 25:1470–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nanda JS, Awadallah WN, Kohrt SE, Popovics
P, Cates JM, Mirosevich J, Clark PE, Giannico GA and Grabowska MM:
Nuclear factor I/B increases in prostate cancer to support androgen
receptor activation. BioRxiv. Jun 27–2019.(Epub ahead of print).
doi: 10.1002/pros.24019.
|
9
|
Wu C, Zhu X, Liu X, Ruan T, Wan W and Tao
K: NFIB promotes cell growth, aggressiveness, metastasis and EMT of
gastric cancer through the Akt/Stat3 signaling pathway. Oncol Rep.
40:1565–1573. 2018.PubMed/NCBI
|
10
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
You X, Vlatkovic I, Babic A, Will T,
Epstein I, Tushev G, Akbalik G, Wang M, Glock C, Quedenau C, et al:
Neural circular RNAs are derived from synaptic genes and regulated
by development and plasticity. Nat Neurosci. 18:603–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang
Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in cancer:
Emerging functions in hallmarks, stemness, resistance and roles as
potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sun H, Xi P, Sun Z, Wang Q, Zhu B, Zhou J,
Jin H, Zheng W, Tang W, Cao H and Cao X: Circ-SFMBT2 promotes the
proliferation of gastric cancer cells through sponging miR-182-5p
to enhance CREB1 expression. Cancer Manag Res. 16:5725–5734. 2018.
View Article : Google Scholar
|
14
|
Zhang Y, Liu H, Li W, Yu J, Li J, Shen Z,
Ye G, Qi X and Li G: CircRNA_100269 is downregulated in gastric
cancer and suppresses tumor cell growth by targeting miR-630. Aging
(Albany NY). 9:1585–1593. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Iqbal N and Iqbal N: Human epidermal
growth factor receptor 2 (HER2) in cancers: Overexpression and
therapeutic implications. Mol Biol Int. 2014:8527482014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yan M, Schwaederle M, Arguello D, Millis
SZ, Gatalica Z and Kurzrock R: HER2 expression status in diverse
cancers: Review of results from 37,992 patients. Cancer Metastasis
Rev. 34:157–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Abrahao-Machado LF and Scapulatempo-Neto
C: HER2 testing in gastric cancer: An update. World J
Gastroenterol. 22:4619–4625. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Hu J and He X: Enhanced quantile
normalization of microarray data to reduce loss of information in
gene expression profiles. Biometrics. 63:50–59. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang Y, Wen L and Zhu H: Unveiling the
hidden function of long non-coding RNA by identifying its major
partner-protein. Cell Biosci. 5:592015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
caner. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI
|
22
|
Qiu L, Wang T, Ge Q, Xu H, Wu Y, Tang Q
and Chen K: Circular RNA signature in hepatocellular carcinoma. J
Cancer. 10:3361–3372. 2019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Vo J, Cieslik M, Zhang Y, Shukla S, Xiao
L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, et al: The
landscape of circular RNA in cancer. Cell. 176:869–881. 2019.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Fang X, Wen J, Sun M, Yuan Y and Xu Q:
CircRNAs and its relationship with gastric cancer. J Cancer.
10:6105–6113. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Shi P, Wan J, Song H and Ding X: The
emerging role of circular RNAs in gastric cancer. Am J Cancer Res.
8:1919–1932. 2018.PubMed/NCBI
|
28
|
Zhu Z, Rong Z, Luo Z, Yu Z, Zhang J, Qiu Z
and Huang C: Circular RNA circNHSL1 promotes gastric cancer
progression through the miR-1306-3p/SIX1/vimentin axis. Mol Cancer.
18:1262019. View Article : Google Scholar : PubMed/NCBI
|
29
|
Perron G, Jandaghi P, Solanki S,
Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis AI, Arseneault
M, Scelo G, Banks RE, et al: A general framework for interrogation
of mRNA stability programs identifies RNA-binding proteins that
govern cancer transcriptomes. Cell Rep. 23:1629–1650. 2018.
View Article : Google Scholar
|
30
|
Benjamin D and Moroni C: mRNA stability
and cancer: An emerging link? Expert Opin Biol Ther. 7:1515–1529.
2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Sun X, Hu Y, Wu J, Shi L, Zhu L, Xi PW,
Wei JF and Ding Q: RBMS2 inhibits the proliferation by stabilizing
P21 mRNA in breast cancer. J Exp Clin Cancer Res. 37:2982018.
View Article : Google Scholar : PubMed/NCBI
|